SCHEMBL32688397

SCHEMBL32688397

COc1ccc(-c2ccc(C=C(C#N)C(N)=S)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.59
ALDH1A1 P00352 8/20 0.59
GAA P10253 2/20 0.59
HTT P42858 1/20 0.59
ATM Q13315 1/20 0.59
KMT2A Q03164 6/20 0.58
KDM4E B2RXH2 5/20 0.58
HPGD P15428 5/20 0.58
BLM P54132 4/20 0.55
CYP1A2 P05177 4/20 0.55
NPSR1 Q6W5P4 3/20 0.55
CYP3A4 P08684 3/20 0.55
TSHR P16473 3/20 0.55
NFKB1 P19838 3/20 0.55
APEX1 P27695 3/20 0.55
PMP22 Q01453 3/20 0.55
TDP1 Q9NUW8 5/20 0.55
MEN1 O00255 4/20 0.55
MAPK1 P28482 2/20 0.55
L3MBTL1 Q9Y468 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4875635 0.95 MAPT (0.64) MAPTALDH1A1GAAHTTATM
SCHEMBL32687985 0.87 MAPT (0.49) MAPTALDH1A1GAAHTTATM
SCHEMBL13060202 0.82 MAPT (0.72) MAPTALDH1A1KMT2AKDM4EHPGD
SCHEMBL32688162 0.81 MAPT (0.66) MAPTALDH1A1GAAHTTATM
SCHEMBL32688040 0.81 TDP1 (0.64) MAPTALDH1A1GAAHTTATM
SCHEMBL21637629 0.81 ALDH1A1 (0.59) MAPTALDH1A1KDM4EHPGDBLM
SCHEMBL21625778 0.81 ALDH1A1 (0.59) MAPTALDH1A1KDM4EHPGDBLM
SCHEMBL21625782 0.81 ALDH1A1 (0.59) MAPTALDH1A1KDM4EHPGDBLM
SCHEMBL22259767 0.80 CYP1A2 (0.68) MAPTALDH1A1GAAKMT2AKDM4E
SCHEMBL32687969 0.80 ALDH1A1 (0.64) MAPTALDH1A1GAAHTTATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK MAPT 4018/4885ALDH1A1 290/4885GAA 1309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.